Necrotic enteritis also called as necrotizing enterocolitis is inflammatory bowel disease found prematurely born infants. Premature infants are defined as infants which are born before 37 weeks of pregnancy. According to the world health organization (WHO) every year around 15 million premature babies are born worldwide and the number is increasing at a steady rate and approximately 1 million babies die due to this condition. The top ten countries include India with the highest number of preterm births followed by China, Nigeria, Pakistan, Indonesia, U.S., Bangladesh, Philippines, Congo, and Brazil. Although causes of necrotic enteritis are not clear but recently in December 2018, researchers at Johns Hopkins University School of Medicine found the molecular cause of the condition and it is likely to be associated with the brain injury. The likelihood of occurrence of necrotic enteritis increases in the preterm born infants who suffer from infection. Around 10 – 12% of preterm born infants suffer from necrotic enteritis and most of them lead to death.
Necrotic Enteritis Treatment Market: Drivers and Restraints
Increasing incidence of the preterm births in the developed, as well as developing countries, remains one of the major market driving factor in the necrotic enteritis treatment market. The increasing access to good healthcare and increasing awareness, as well as medical attention to pregnancy-related complications further, improve the treatment-seeking rate driving the growth of necrotic enteritis treatment market. The necrotic enteritis treatment market is highly driven by the ongoing research to find a causative factor and breakthrough results may increase the revenue generation significantly in near future. Increasing funding by probiotic manufacturing companies in the research and development in the necrotic enteritis treatment market further expected to fuel the market growth. Whereas, time-consuming nature of developing new breakthrough treatments may hamper the necrotic enteritis treatment market growth. The unknown cause of necrotic enteritis further keeps treatment options limited and most often not effective as desired in turn limiting the necrotic enteritis treatment revenue generation.
To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-8316
Necrotic Enteritis Treatment Market: Overview
The necrotic enteritis treatment market is dominated by the strong pipeline presence of the various drugs that can be used as necrotic enteritis treatment. The FDA has granted orphan drug designation to some of the products which are still in the clinical stage of development for necrotic enteritis treatment such as FDA granted BioGaia Probiotics clinical stage product orphan drug designation in 2013. By drug class, necrotic enteritis treatment market is expected to be dominated by Inter-Alpha-Inhibitor-Proteins (“IaIp”) due to comparatively superior efficacy. By distribution channel, necrotic enteritis treatment market is expected to be dominated by hospital pharmacies due to higher patient footfall for the treatment.
Necrotic Enteritis Treatment Market: Regional Outlook
The global necrotic enteritis treatment market is expected to be dominated by North America necrotic enteritis treatment market due to higher treatment seeking rate. Asia-Pacific is expected to be the second most lucrative necrotic enteritis treatment market due to the high incidence of preterm births in the region. India and China are one of leading countries in the number of preterm births per year which can significantly impact necrotic enteritis treatment market. Although the incidence of preterm births is higher in the APAC region, low treatment seeking rate and low product adoption hampers potential revenue generation of necrotic enteritis treatment market. Europe remains the third most lucrative necrotic enteritis treatment market due to increasing product adoption for necrotic enteritis treatment. Latin America necrotic enteritis treatment market expected to maintain steady growth due gradually increasing treatment-seeking rate preterm born infants. The Middle East and Africa necrotic enteritis treatment market remain least lucrative due to low treatment seeking rate, low awareness about preterm birth conditions related complications.
Necrotic Enteritis Treatment Market: Key Players
The key players operating in the global necrotic enteritis treatment market are: Prometic Life Sciences Inc., BioGaia Probiotics, Fresenius Kabi AG, Actavis Plc., Bayer International, Alcon Laboratories, Inc., Bausch & Lomb Incorporated, GlaxoSmithKline plc. And Others.
For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-8316
Why Future Market Insights?
• Comprehensive analysis on evolving purchase pattern across different geographies
• Detailed insights of market segments and sub-segments for historical as well as forecast period
• A competitive analysis of prominent players and emerging players in the keyword market
• Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years
Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario
About FMI:
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.
Contact Us:
Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com